Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Journal Article
Koletsa, T., Patsatsi A., Kostopoulos I., Kartsios C., Korantzis I., & Sotiriadis D. (2012).  A case of a primary cutaneous plasmacytoma presenting in adolescence.. Am J Dermatopathol. 34(5), 537-40.
Tzikas, S., & Papadopoulos C. (2018).  A Case of a Paracardial Osteophyte Causing Atrial Compression.
Tzikas, S., Triantafyllou K., Papadopoulos C., & Vassilikos V. (2016).  A Case of a Paracardial Osteophyte Causing Atrial Compression.. Case Rep Med. 2016, 4325830.
Charokopos, N. A., Antonitsis P., Rouska E., Kostopoulos I., Charaf A., & Spanos P. K. (2006).  Cartilaginous and osseous metaplasia with bone marrow formation in the aortic valve of a patient with giant cell aortitis.. Ann Thorac Surg. 81(5), 1877-9.
Ioannou, A., Makedou K., Argiriou A., Destanis E., Pantoleon A., Zormpa A., et al. (2016).  Carotid Intima-media Thickness, Paraoxonase-1 Gene Polymorphism, Inflammation and Oxidation Status in Children with Family History of Premature Cardiovascular Diseases. Cardiology and Angiology: An International Journal. 5(2), 1 - 8.
Theocharidou, E., Gossios T. D., Giouleme O., Athyros V. G., & Karagiannis A. (2014).  Carotid intima-media thickness in patients with inflammatory bowel disease: a systematic review.. Angiology. 65(4), 284-93.
Stavropoulos, K., Imprialos K. P., Doumas M., & Athyros V. G. (2018).  Carotid intima-media thickness as a target-organ damage and treatment-target: Need for a major revision?. J Clin Hypertens (Greenwich). 20(2), 255-257.
Papademetriou, V., Doumas M., Faselis C., Tsioufis C., Douma S., Gkaliagkousi E., et al. (2011).  Carotid baroreceptor stimulation for the treatment of resistant hypertension.. Int J Hypertens. 2011, 964394.
Doumas, M., Guo D., & Papademetriou V. (2009).  Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions.. Expert Opin Ther Targets. 13(4), 413-25.
Doumas, M., Faselis C., Kokkinos P., Anyfanti P., Tsioufis C., & Papademetriou V. (2014).  Carotid baroreceptor stimulation: a promising approach for the management of resistant hypertension and heart failure.. Curr Vasc Pharmacol. 12(1), 30-7.
Skandalakis, G. P., Koutsarnakis C., Pantazis N., Kalyvas A., Komaitis S., Lani E., et al. (2019).  The carotico-clinoid bar: A systematic review and meta-analysis of its prevalence and potential implications in cerebrovascular and skull base surgery.. World Neurosurg.
Evangeliou, A., Gourgiotis D., Karagianni C., Markouri M., Anogianaki N., Mamoulakis D., et al. (2010).  Carnitine status and lactate increase in patients with type I juvenile diabetes.. Minerva Pediatr. 62(6), 551-7.
Courcoutsakis, N., Prassopoulos P., & Stratakis C. (2015).  Carney Complex: One More Entity with Skin and Bone Manifestations. RadioGraphics. 35(1), 296 - 297.
Godosis, D., Komaitis S., Tziomalos K., Baltatzi M., Ntaios G., Savopoulos C. G., et al. (2012).  Cardiοvascular diseases in pregnancy.. Am J Cardiovasc Dis. 2(2), 96-101.
Karagiannis, T., Bekiari E., Boura P., & Tsapas A. (2016).  Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.. Ther Adv Drug Saf. 7(2), 36-8.
Karagiannis, T., Bekiari E., Boura P., & Tsapas A. (2016).  Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications. Therapeutic Advances in Drug Safety. 7(2), 36 - 38.
Athyros, V. G., Katsiki N., & Karagiannis A. (2013).  Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients.. Curr Med Res Opin. 29(7), 791-2.
Patriki, D., & Giannopoulos A. A. (2018).  Cardiovascular risk prediction models with myocardial perfusion imaging in chronic kidney disease: ACCESSing digits or focusing on the patient?. J Nucl Cardiol.
Zegkos, T., Kitas G., & Dimitroulas T. (2016).  Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps.. Ther Adv Musculoskelet Dis. 8(3), 86-101.
Gkaliagkousi, E., Gavriilaki E., Aslanidis S., & Douma S. (2014).  Cardiovascular risk in psoriatic arthritis: should we focus on hypertension and diabetes only?. Clin Exp Rheumatol. 32(6), 995.
Tziomalos, K., Athyros V. G., & Karagiannis A. (2015).  Cardiovascular Risk in Middle East Populations: A Call to Action.. Angiology. 66(9), 801-2.
Gazzaruso, C., Gola M., Karamouzis I., Giubbini R., & Giustina A. (2014).  Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update.. J Clin Endocrinol Metab. 99(1), 18-29.
Chimonas, T., Athyros V. G., Ganotakis E., Nicolaou V., Panagiotakos D. B., Mikhailidis D. P., et al. (2010).  Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome.. Angiology. 61(1), 49-57.
Triantafyllou, A., & Douma S. (2019).  Cardiovascular risk assessment in elderly individuals without overt CVD disease. Could traditional risk factors fit in all ages?. J Clin Hypertens (Greenwich). 21(8), 1153-1154.
Athyros, V. G., Tziomalos K., Katsiki N., Doumas M., Karagiannis A., & Mikhailidis D. P. (2015).  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.. World J Gastroenterol. 21(22), 6820-34.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές